DEXCOM INC - Common Stock (DXCM)

1,127 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q4 2024.
DEXCOM INC - Common Stock (DXCM) has 940 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 356,520,250 shares of 392,193,323 outstanding shares and own 91% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (46,530,017 shares), BlackRock, Inc. (39,599,601 shares), STATE STREET CORP (16,686,230 shares), BAILLIE GIFFORD & CO (14,612,792 shares), Capital Research Global Investors (14,371,751 shares), SANDS CAPITAL MANAGEMENT, LLC (11,109,501 shares), GEODE CAPITAL MANAGEMENT, LLC (9,993,698 shares), Nuveen Asset Management, LLC (8,138,522 shares), JENNISON ASSOCIATES LLC (7,643,757 shares), and UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (7,198,284 shares).
This table shows the top 940 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.